Is iL13 gene polymorphism a marker for psoriatic arthritis among psoriasis patients?
IL13 gene polymorphism is associated with increased susceptibility to PsA in psoriasis patients.
During CPR, only a fifth of patients received appropriate treatment of the primary cause underlying PEA. Those patients were more likely to be alive 30 days after IHCA, but age turned out to be the only significant individual factor for better survival.